Drug Trial Radar · NCT00206583
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
Last checked: Nov 20, 2026Latest source record: Oct 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
499
Actual
Start
Mar 2005
Primary completion
Jun 2007
Study completion Jul 2007
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Sep 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the study drug is safe and effective in the prevention of pregnancies in a large group of volunteers.
Conditions
- Contraception
Interventions
EV/DNG (Qlaira, BAY86-5027, SH T00658ID)Drug
GA: Estradiolvalerate (EV)/Dienogest (DNG) Tablet p.o. (oral) Tablet, p.o. (oral)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of unintended pregnancies after 1 yearTime frame: Throughout 1 year of treatment
Locations
29 sites in 2 countries. Site status is shown where the registry gives one.
Women and Children's Hospital, Los Angeles
Los Angeles, California
Lifespan Research
Palo Alto, California
Genesis Center for Clinical Research
San Diego, California
Medical Center for Clinical Research
San Diego, California
Harbor - UCLA Medical Center
Torrance, California
Clinical Trial Center of Colorado
Castle Rock, Colorado
New Age Medical Research Corp.
Miami, Florida
Visions Clinical Research
Palm Springs, Florida
Insignia Care for Women, P.A.
Tampa, Florida
Comprehensive Clinical Trials
West Palm Beach, Florida
Physicians Research Group
Indianapolis, Indiana
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Women's Clinic of Lincoln, PC
Lincoln, Nebraska
Women's Care Source
Morristown, New Jersey
OB/GYN Health Center
Medford, Oregon
Oregon Health and Science University
Portland, Oregon
Clinical Research of Philadelphia, LLC
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center Health System
Pittsburgh, Pennsylvania
Eastern Virginia Medical School
Norfolk, Virginia
Seattle Women's: Health, Research, Gynecology
Seattle, Washington
Total Concept Health Care Inc.
Kitchener, Ontario, Canada
Temple Green Clinic
Waterloo, Ontario, Canada
Rhodin Recherche Clinique
Drummondville, Quebec, Canada
Centre d'étude clinique de Montréal Inc.
Montreal, Quebec, Canada
Les Gynecologues Associes
Montreal, Quebec, Canada
Clinique Recherche en Sante des Femmes Inc.
Québec, Quebec, Canada
Clinique de Gynecologie
Shawinigan, Quebec, Canada
Diex Recherche Inc.
Sherbrooke, Quebec, Canada
Clinique Médicale des Campus
Ste-Foy, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.